Abstract:Background
Machine learning (ML) provides novel opportunities for human behavior research and clinical translation, yet its application can have noted pitfalls (Bone et al., 2015). In this work, we fastidiously utilize ML to derive autism spectrum disorder (ASD) instrument algorithms in an attempt to improve upon widely-used ASD screening and diagnostic tools.
Methods
The data consisted of Autism Diagnostic Interview-Revised (ADI-R) and Social Responsiveness Scale (SRS) scores for 1,264 verbal individuals wi… Show more
“…Consequently, there is insufficient coverage for ASD construct validity based on unique ASD symptom co-expression. Some researchers have proposed to make ASD more homogeneous by refining ASD diagnostic criteria Sonuga-Barke 2016) and by developing more sensitive ASD diagnostic screening instruments (Bone et al 2016). However, it is unlikely that the many nondiagnostic symptoms such as ADHD, ID, epilepsy, and language impairment that occur with ASD that stem from varied ASD brain impairments caused by varied ASD risk factors (Kida and Kato 2015) will be eliminated by refinement of the ASD criteria or refinement of ASD screening measures.…”
Section: Criteria Validity Research Approach 2: Do the Two Core Asd Dmentioning
ASD research is at an important crossroads. The ASD diagnosis is important for assigning a child to early behavioral intervention and explaining a child's condition. But ASD research has not provided a diagnosis-specific medical treatment, or a consistent early predictor, or a unified life course. If the ASD diagnosis also lacks biological and construct validity, a shift away from studying ASD-defined samples would be warranted. Consequently, this paper reviews recent findings for the neurobiological validity of ASD, the construct validity of ASD diagnostic criteria, and the construct validity of ASD spectrum features. The findings reviewed indicate that the ASD diagnosis lacks biological and construct validity. The paper concludes with proposals for research going forward.Keywords DSM-5 . ASD . Autism . Diagnosis . Validity . Comorbidity . HeterogeneityThe goal of the DSM-3 nosology (American Psychiatric Association 1980) was to create reliable and standard categorical psychiatric diagnoses (Robins and Guze 1970). However, in the past 30 years, clinical, genetics, and neuroscience findings have revealed that the DSM diagnoses are not biologically valid. The National Institutes of Mental Health (NIMH) responded by proposing the Research Domain Criteria (RDoC) framework for a brain-based transdiagnostic psychiatric symptom nosology (Cuthbert and Insel 2013;Insel et al. 2010;Lilienfeld and Treadway 2016). Peterson (2015) and Weinberger et al. (2015) argued that the RDoC could not replace the DSM-5 psychiatric nosology (American Psychiatric Association 2013) or the parallel International Classification of Diseases (ICD) psychiatric nosology (World Health Organization 2012). But BFor the foreseeable future, RDoC is not envisioned as a system of psychiatric classification in its own right. Instead, in the near term, RDoC and DSM-ICD are expected to coexist. Nevertheless, RDoC is intended to provide scaffolding for a large-scale research program that will ultimately yield an alternative to DSM-ICD^ (Lilienfeld and Treadway 2016, p. 445).RDoC advocates accept that DSM-5/ICD psychiatric categories remain necessary in clinical practice, but argue that researchers should shift to RDoC study designs immediately. They assert that studying psychiatric categories lacking biological validity blocks the discovery of brain bases for psychopathology and thus cannot lead to effective medical treatments for specific psychiatric symptoms (Cuthbert and Insel 2013;Insel et al. 2010;Lilienfeld and Treadway 2016;Yee et al. 2015). Against this RDoC imperative for biological validity, Weinberger et al. (2015) countered that current DSM-5 psychiatric behavioral diagnoses were valid when they yielded effective medical treatment, clear prognosis, and a life course specific to a diagnosis.Autism spectrum disorder (ASD) research has been productive (Dawson 2016;de la Torre-Ubieta et al. 2016;Szatmari et al. 2016), but no ASD research findings have met the validity criteria of Weinberger et al. (2015). DSM-5 ASD research has found no s...
“…Consequently, there is insufficient coverage for ASD construct validity based on unique ASD symptom co-expression. Some researchers have proposed to make ASD more homogeneous by refining ASD diagnostic criteria Sonuga-Barke 2016) and by developing more sensitive ASD diagnostic screening instruments (Bone et al 2016). However, it is unlikely that the many nondiagnostic symptoms such as ADHD, ID, epilepsy, and language impairment that occur with ASD that stem from varied ASD brain impairments caused by varied ASD risk factors (Kida and Kato 2015) will be eliminated by refinement of the ASD criteria or refinement of ASD screening measures.…”
Section: Criteria Validity Research Approach 2: Do the Two Core Asd Dmentioning
ASD research is at an important crossroads. The ASD diagnosis is important for assigning a child to early behavioral intervention and explaining a child's condition. But ASD research has not provided a diagnosis-specific medical treatment, or a consistent early predictor, or a unified life course. If the ASD diagnosis also lacks biological and construct validity, a shift away from studying ASD-defined samples would be warranted. Consequently, this paper reviews recent findings for the neurobiological validity of ASD, the construct validity of ASD diagnostic criteria, and the construct validity of ASD spectrum features. The findings reviewed indicate that the ASD diagnosis lacks biological and construct validity. The paper concludes with proposals for research going forward.Keywords DSM-5 . ASD . Autism . Diagnosis . Validity . Comorbidity . HeterogeneityThe goal of the DSM-3 nosology (American Psychiatric Association 1980) was to create reliable and standard categorical psychiatric diagnoses (Robins and Guze 1970). However, in the past 30 years, clinical, genetics, and neuroscience findings have revealed that the DSM diagnoses are not biologically valid. The National Institutes of Mental Health (NIMH) responded by proposing the Research Domain Criteria (RDoC) framework for a brain-based transdiagnostic psychiatric symptom nosology (Cuthbert and Insel 2013;Insel et al. 2010;Lilienfeld and Treadway 2016). Peterson (2015) and Weinberger et al. (2015) argued that the RDoC could not replace the DSM-5 psychiatric nosology (American Psychiatric Association 2013) or the parallel International Classification of Diseases (ICD) psychiatric nosology (World Health Organization 2012). But BFor the foreseeable future, RDoC is not envisioned as a system of psychiatric classification in its own right. Instead, in the near term, RDoC and DSM-ICD are expected to coexist. Nevertheless, RDoC is intended to provide scaffolding for a large-scale research program that will ultimately yield an alternative to DSM-ICD^ (Lilienfeld and Treadway 2016, p. 445).RDoC advocates accept that DSM-5/ICD psychiatric categories remain necessary in clinical practice, but argue that researchers should shift to RDoC study designs immediately. They assert that studying psychiatric categories lacking biological validity blocks the discovery of brain bases for psychopathology and thus cannot lead to effective medical treatments for specific psychiatric symptoms (Cuthbert and Insel 2013;Insel et al. 2010;Lilienfeld and Treadway 2016;Yee et al. 2015). Against this RDoC imperative for biological validity, Weinberger et al. (2015) countered that current DSM-5 psychiatric behavioral diagnoses were valid when they yielded effective medical treatment, clear prognosis, and a life course specific to a diagnosis.Autism spectrum disorder (ASD) research has been productive (Dawson 2016;de la Torre-Ubieta et al. 2016;Szatmari et al. 2016), but no ASD research findings have met the validity criteria of Weinberger et al. (2015). DSM-5 ASD research has found no s...
“…The results are promising (Bonneh, Levanon, Dean-Pardo, Lossos, & Adini, 2011;Faurholt-Jepsen et al, 2016;Martínez-Sánchez et al, 2015;Rapcan et al, 2010;Tsanas et al, 2011;7 VOICE IN SCHIZOPHRENIA: REVIEW AND META-ANALYSIS Williams et al, 2014), but a complete and comparative overview of the findings in schizophrenia is currently missing. Crucially, the reliability of ML results has been shown to be strongly dependent on the availability of large datasets and the validation of the findings across datasets (Bone et al, 2016;Chekroud, 2018;Foody, 2017;James et al, 2013;Van Der Ploeg et al, 2014), which presence we wanted to assess in the literature on voice in schizophrenia.…”
Voice atypicalities have been a characteristic feature of schizophrenia since its first definitions. They are often associated with core negative symptoms such as flat affect and alogia, and with the social impairments seen in the disorder. This suggests that voice atypicalities may represent a marker of clinical features and social functioning in schizophrenia. We systematically reviewed and meta-analyzed the evidence for distinctive acoustic patterns in schizophrenia, as well as their relation to clinical features. We identified 46 articles, including 55 studies with a total of 1254 patients with schizophrenia and 699 healthy controls. Summary effect sizes (Hedges'g and Pearson's r) estimates were calculated using multilevel Bayesian modeling. We identified weak atypicalities in pitch variability (g = -0.55) related to flat affect, and stronger atypicalities in proportion of spoken time, speech rate, and pauses (g's between -0.75 and -1.89) related to alogia and flat affect. However, the effects were mostly modest (with the important exception of pause duration) compared to perceptual and clinical judgments, and characterized by large heterogeneity between studies.Moderator analyses revealed that tasks with a more demanding cognitive and social component showed larger effects both in contrasting patients and controls and in assessing symptomatology. In conclusion, studies of acoustic patterns are a promising but, yet unsystematic avenue for establishing markers of schizophrenia. We outline recommendations towards more cumulative, open, and theory-driven research.
“…Child-adult interactions have been used in the ASD domain primarily for diagnosis (ADOS [5]) and measuring intervention response (BOSCC [6]). Automated computational processing of the participants' audio [7] and language streams [8] has provided objective descriptions that characterize the session progress and understanding the relation with symptom severity.…”
Computational modeling of naturalistic conversations in clinical applications has seen growing interest in the past decade. An important use-case involves child-adult interactions within the autism diagnosis and intervention domain. In this paper, we address a specific sub-problem of speaker diarization, namely child-adult speaker classification in such dyadic conversations with specified roles. Training a speaker classification system robust to speaker and channel conditions is challenging due to inherent variability in the speech within children and the adult interlocutors. In this work, we propose the use of meta-learning, in particular prototypical networks which optimize a metric space across multiple tasks. By modeling every child-adult pair in the training set as a separate task during meta-training, we learn a representation with improved generalizability compared to conventional supervised learning. We demonstrate improvements over state-of-theart speaker embeddings (x-vectors) under two evaluation settings: weakly supervised classification (upto 14.53% relative improvement in F1-scores) and clustering (upto relative 9.66% improvement in cluster purity). Our results show that protonets can potentially extract robust speaker embeddings for child-adult classification from speech.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.